These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 18431326)

  • 1. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
    Reddan D; Fishman EK
    Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of contrast-induced nephropathy.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.
    Persson PB; Patzak A
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i2-5. PubMed ID: 15705945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy.
    Bartorelli AL; Marenzi G
    J Interv Cardiol; 2008 Feb; 21(1):74-85. PubMed ID: 18086132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.